OMD, Osteomodulin (osteoadherin) is a KS‐SLRP that binds to osteoblasts via αVβ3 integrin and regulates osteogenesis through its interaction with BMP2. WNT1 transcriptionally activates the expression of OMD. The gene discussed is BMP2; the disease is occult macular dystrophy.